vimarsana.com

Page 4 - Palmoplantar Keratoderma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oral Supplementation with Algal Sulphated Polysaccharide in Subjects w by Lauren A Roach, Barbara J Meyer et al

We examined the effect of a dietary seaweed extract-sulfated xylorhamnoglucuronan (SXRG84)-on individuals with inflammatory skin conditions. A subgroup analysis of a larger trial was undertaken, where 44 participants with skin conditions were enrolled in a double-blind placebo-controlled crossover design. Subjects ingested either SXRG84 extract (2 g/day) for six weeks and placebo for six weeks, or vice versa. At baseline, six- and twelve-weeks inflammatory markers and the gut microbiota were assessed, as well as skin assessments using the dermatology quality of life index (DQLI), psoriasis area severity index (PASI) and visual analogue scales (VAS). There were significant differences at weeks six and twelve for pro-inflammatory cytokines IFN-γ (p = 0.041), IL-1β (p = 0.030), TNF-α (p = 0.008) and the anti-inflammatory cytokine IL-10 (p = 0.026), determined by ANCOVA. These cytokines were all significantly higher at six weeks post placebo compared to twelve weeks post placebo followe

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.